University of Thessaly (UTH)
Υποδιάγνωση της κοινής ποικίλης ανοσοανεπάρκειας στην Ελλάδα
Abstract
dc:descriptionCommon Variable Immunodeficiency (CVID) is the most frequently occurring primary immunodeficiency in humans, typically characterized by hypogammaglobulinemia, which leads to the hallmark symptom of recurrent infections. Despite extensive research, the genetic basis of the disease remains unknown for the majority of patients. Beyond infections, the broader dysfunction of the immune system contributes to a range of comorbidities, including autoimmune manifestations, lymphoproliferation, granulomatous disease, and malignancies. Underdiagnosis and delayed diagnosis of CVID remain major barriers to effective disease management, significantly affecting patient quality of life and health outcomes worldwide. This study presents the results of the first nationwide registry of CVID patients in Greece. Our goal was to estimate the degree of underdiagnosis, identify the clinical phenotypes observed among Greek patients, and explore how clinical presentation relates to diagnostic delay.Using a comprehensive data collection form covering the full clinical profile of each patient, we recorded 153 individuals from 10 collaborating centers over an eight-year period (2015–2023). Patients were classified into subgroups: (i) the entire cohort, (ii) those who had received chemotherapy prior to CVID diagnosis (Group B), (iii) patients with selective IgA and IgG subclass deficiencies (Group C), (iv) patients with CTLA4 gene mutations (Group D), and (v) patients with unclassified agammaglobulinemia (Group E). Across the total cohort, the average diagnostic delay was 9.0 years, with Group C experiencing the longest delay (mean: 12.0 years). At the time of diagnosis, average immunoglobulin levels were: IgG 299.6 ± 231 mg/dL, IgA 21.2 ± 42.6 mg/dL, and IgM 41.4 ± 61.6 mg/dL. Autoimmune features were present in 56.9% of patients, while splenomegaly was observed in 49.0%. Group D had the highest rate of enteropathy (60.0%). Granulomatous disease was reported in 10.4% of patients, and 16.3% developed malignancies, most commonly B-cell lymphomas. Diagnostic delays were associated with worsened clinical outcomes across all groups, including serious complications such as bronchiectasis and chronic obstructive pulmonary disease. In most cases, lymphoproliferation co-occurred with autoimmunity, splenomegaly, and enteropathy, forming a recognizable clinical pattern. Patient subgrouping revealed insights into the relationship between underdiagnosis and clinical phenotype that would otherwise remain hidden. Systematic national and international registries play a crucial role in demystifying CVID and enabling earlier diagnosis. Achieving this requires the establishment of standardized protocols for diagnosis, documentation, and follow-up that fully capture the disease’s clinical spectrum on a patient-by-patient basis.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kapousouzi, Androniki
- Καπουσούζη, Ανδρονίκη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61529